TabletsClinical Overview
Fluoxetine Hydrochloride is a prototype selective serotonin reuptake inhibitor (SSRI) on the WHO Model List of Essential Medicines. It blocks the presynaptic serotonin transporter (SERT) and possesses a long elimination half-life (1-3 days for parent drug, 7-15 days for active norfluoxetine), providing a built-in buffer against abrupt discontinuation syndrome. Also displays mild 5-HT2C antagonism, contributing to energizing/activating effects. Indicated for major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally once daily in the morning with a glass of water, with or without meals. Morning dosing prevents sleep disruption. Swallow capsules whole. Follow physician's directions.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, insomnia, anxiety, nervousness, tremor, anorexia, weight loss, sexual dysfunction. Rare/Severe: Boxed warning: Suicidal ideation; serotonin syndrome, mania switch in bipolar disorder, seizures, and severe hyponatremia.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Black box warning for suicidality in children and young adults. Due to prolonged half-life, a 5-week washout period is mandatory before initiating an MAO inhibitor. Potent inhibitor of CYP2D6; interacts with tamoxifen, metoprolol, and tricyclic antidepressants.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Fluoxetine Hydrochloride Capsules 20mg
Fluoxetine Hydrochloride is a prototype selective serotonin reuptake inhibitor (SSRI) on the WHO Model List of Essential Medicines. It blocks the presynaptic serotonin transporter (SERT) and possesses a long elimination half-life (1-3 days for parent drug, 7-15 days for active norfluoxetine), providing a built-in buffer against abrupt discontinuation syndrome. Also displays mild 5-HT2C antagonism, contributing to energizing/activating effects. Indicated for major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder.
Alprazolam 0.25mg + Fluoxetine 20mg Tablets
Alprazolam and Fluoxetine combines a fast-acting triazolobenzodiazepine with a selective serotonin reuptake inhibitor (SSRI). Alprazolam rapidly relieves acute psychic anxiety, insomnia, and agitation within hours, while fluoxetine provides sustained long-term modulation of central serotonergic pathways to treat underlying depressive and panic pathology over weeks. Indicated for major depressive disorder with comorbid anxiety or agitation.
Olanzapine Tablets 10mg
Olanzapine is a second-generation atypical thienobenzodiazepine antipsychotic and mood stabilizer on the WHO Model List of Essential Medicines. It acts by antagonizing serotonin 5-HT2A and dopamine D2 receptors, with high affinity for 5-HT2C, H1, and alpha-1 receptors, delivering potent antipsychotic efficacy with low extrapyramidal liability. Indicated for schizophrenia, acute manic or mixed episodes in bipolar I disorder, maintenance in bipolar disorder, and treatment-resistant depression (in combination with fluoxetine).
Olanzapine Tablets 5mg
Olanzapine is a second-generation atypical thienobenzodiazepine antipsychotic and mood stabilizer on the WHO Model List of Essential Medicines. It acts by antagonizing serotonin 5-HT2A and dopamine D2 receptors, with high affinity for 5-HT2C, H1, and alpha-1 receptors, delivering potent antipsychotic efficacy with low extrapyramidal liability. Indicated for schizophrenia, acute manic or mixed episodes in bipolar I disorder, maintenance in bipolar disorder, and treatment-resistant depression (in combination with fluoxetine).